IL-6-174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma

OMICS A Journal of Integrative Biology

Volumn 15, Issue 3, 2011, Pages 183-186

  Giannitrapani, Lydia ^a   Soresi, Maurizio ^a   Giacalone, Antonio ^a   Campagna, Maria Elisa ^a   Marasà, Marta ^b   Cervello, Melchiorre ^c   Marasà, Salvatore ^b   Montalto, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Gastroenterology Unit   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTERLEUKIN 6;

ALLELE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-6; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79952523091     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2010.0093     Document Type: Article

References (20)

1. The Cancer of Liver Italian Programme (CLIP) Investigators prospective validation of the Clip score. (2000). A new prognostic system for patient with cirrhosis and hepatocellular carcinoma. Hepatology 31, 840-845.
2. Berasain, C., Castillo, J., Perugorria, M. J., Latasa, M. U., Prieto, J., and Avila, M. A. (2009). Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 1155, 206-221.
3. Bruix, J., and Sherman. M. (2005). Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42, 1208-1236.
4. Coussens, L. M., and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867. (Pubitemid 36019639)
5. Giannitrapani, L., Cervello, M., Soresi, M., Notarbartolo, M., La Rosa, M., Virruso, L., et al. (2002). Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma. Ann N Y Acad Sci 963, 46-52. (Pubitemid 34721694)
6. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
7. Kakumu, S., Shinagawa, T., Ishikawa, T., Yoshioka, K., Wakita, T., Ito, Y., et al. (1991). Serum interleukin 6 levels in patients with chronic hepatitis B. Am J Gastroenterol 86, 1804-1808.
8. Karin, M., and Greten, F. R. (2005). NF-kB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5, 749-759. (Pubitemid 41400849)
9. Khoruts, A., Stahnke, L., McClain, C. J., Logan, G., and Allen, J. I. (1991). Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13, 267-276.
10. Li, Q., Withoff, S., and Verma, I. M. (2005). Inflammationassociated cancer: NF-kB is the lynchpin. Trends Immunol 26, 318-325.
11. Llovet, J. M., Burroughs, A., and Bruix, J. (2003). Hepatocellular carcinoma. Lancet 362, 1907-1917. (Pubitemid 37518510)
12. Macarthur M., Hold, G. L., and El-Omar, E. M. (2004). Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286, G515-G520. (Pubitemid 38374969)
13. Nakagawa, H., Maeda, S., Yoshida, H., Tateishi, R., Masuzaki, R, Ohki, T., et al. (2009). Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer 125, 2264-2269.
14. Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., et al. (2007). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124. (Pubitemid 47056470)
15. Porta, C., De Amici, M., Quaglini, S., Paglino, C., Tagliani, F., Boncimino, A., et al. (2008). Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann Oncol 19, 353-358. (Pubitemid 351201719)
16. Prieto, J. (2008). Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol 48, 380-381.
17. Soresi, M., Giannitrapani, L., D'Antona, F., Florena, A. M., La Spada, E., Terranova, A., et al. (2006). Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol 12, 2563-2568.
18. Soresi, M., Tripi, S., Franco, V., Giannitrapani, L., Alessandri, A., Rappa, F., et al. (2006). Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. Liver Int 26, 1119-1125. (Pubitemid 44541753)
19. Sunyer, J., Forastiere, F., Pekkanen, J., Plana, E., Kolz, M., Pistelli, R., et al. (2009). Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers. Nicotine Tob Res 11, 1347-1353.
20. Uboldi de Capei, M., Dametto, E., Fasano, M. E., Rendine, S., and Cartoni, E. S. (2003). Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. Eur J Immunogenet 30, 5-10. (Pubitemid 36241236)